| MDPI | Multidisciplinary Digital Publishing Institute |
| DOAJ | Directory of open access journals |
| WBRT | Whole brain radiation therapy |
| SRS | Stereotactic radiosurgery |
| ICI | Immune checkpoint inhibitors |
| CNS | Central nervous system |
| RPA | Recursive partitioning analysis |
| KPS | Karnofsky Performance Status |
| DS-GPA | Diagnosis Specific–Graded Prognostic Assessment |
| Gy | Gray |
| LC | Local control |
| OS | Overall survival |
| MRI | Magnetic resonance imaging |
| RT | Radiation therapy |
| LINAC | Linear accelerator |
| NCCN | National Comprehensive Cancer Network |
| APC | Antigen presenting cells |
| MHC | Major histocompatibility complex |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| dsDNA | Double-stranded deoxyribonucleic acid |
| STING | STimulator of INterferon Genes |
| DC | Dendritic cells |
| IFN | Interferon |
| ICD | Immunogenic cell death |
| ATP | Adenosine triphosphate |
| TGF-β | Transforming growth factor β |
| Tregs | T regulatory cells |
| TAMs | Tumor associated macrophages |
| DNA | Deoxyribonucleic acid |
| FDA | Food and Drug Administration |
| PD-1 | Programmed death cell protein 1 |
| PD-L1 | Programmed death ligand-1 |
| NSCLC | Non-small cell lung cancer |
| RCC | Renal cell carcinoma |
| CRC | Colorectal cancer |
| HCC | Hepatocellular carcinoma |
| SCLC | Small cell lung cancer |
| BBB | Blood brain barrier |
| VLA-4 | Very late antigen-4 |
| LFA-1 | Leukocyte-function-associated antigen-1 |
| H | Histology |
| M | Melanoma |
| N | Total number of patients |
| NR | Not reported |
| USA | United States of America |